Prodromal symptoms and early intervention to prevent a relapse
ISRCTN | ISRCTN17350364 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN17350364 |
Secondary identifying numbers | N/A |
- Submission date
- 27/01/2006
- Registration date
- 27/01/2006
- Last edited
- 18/08/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr J. Arends
Scientific
Scientific
Department of Psychotic Disorders
Mental Health Care Services Drenthe
P.O. Box 30.007
Assen
9400 RA
Netherlands
Phone | +31 (0)592 334883 |
---|---|
Johan.Arends@GGZDrenthe.nl |
Study information
Study design | Multicentre randomised single blind active controlled parallel group trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Treatment |
Scientific title | |
Study objectives | Could early treatment of prodromal symptoms prevent or postpone a psychotic relapse in schizophrenia? |
Ethics approval(s) | Received from local medical ethics committee |
Health condition(s) or problem(s) studied | Schizophrenia, Schizophreniform disorder |
Intervention | The Symptom Management Module (SMM), one of the independent living skills modules developed by the Los Angeles rehabilitation research group, is a psychosocial intervention to improve the capability of patients with schizophrenia to detect early warning signs (EWS) of a psychosis and to teach the patients to manage them. Two treatment conditions (symptom management module [N = 46] versus self monitoring [N = 52]) and a comparison group (treatment as usual [N = 49]) in patients with schizophrenia or related psychotic disorders. |
Intervention type | Other |
Primary outcome measure | Occurrence of a psychotic relapse: a worsening of at least two points on the CGI as assessed by psychiatrist and verified by researcher by a PANSS-interview within a week. |
Secondary outcome measures | 1. Hospitalisation 2. Psychopathology |
Overall study start date | 01/01/1997 |
Completion date | 01/01/2002 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 147 |
Key inclusion criteria | 1. ICD-10 diagnosis of schizophrenia (F20) or schizoaffective disorder (F25) 2. A remitted state established by no more than one score of 4 on the positive scale of the PANSS 3. Necessary skills in Dutch language to undergo a training in Dutch |
Key exclusion criteria | Substance abuse |
Date of first enrolment | 01/01/1997 |
Date of final enrolment | 01/01/2002 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Department of Psychotic Disorders
Assen
9400 RA
Netherlands
9400 RA
Netherlands
Sponsor information
Mental Health Care Services Drenthe (Netherlands)
Hospital/treatment centre
Hospital/treatment centre
Department of Psychotic Disorders
P.O. Box 30.007
Assen
9400 RA
Netherlands
https://ror.org/0107rkg57 |
Funders
Funder type
Research organisation
Netherlands Organisation for Health Research and Development (ZonMw)
Private sector organisation / Other non-profit organizations
Private sector organisation / Other non-profit organizations
- Alternative name(s)
- Netherlands Organisation for Health Research and Development
- Location
- Netherlands
Support Foundation (Stichting tot Steun) (Netherlands)
No information available
Netherlands Care Cooperative (Zorgcoöperatie Nederland [formerly: De Open Ankh]) (Netherlands)
No information available
The Per V. Petersen Foundation (Netherlands)
No information available
National Foundation of Mental Health Care (Nationaal Fonds Geestelijke Volksgezondheid [NFGV]) (Netherlands)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |